Self assessment.

This Australian pilot trial reports patients randomized to self-led screening after initial diagnosis of melanoma detected 8 (16%) new/recurrent melanomas versus only 3 (6%) in the control group undergoing surveillance at routine clinic visits. | Ackermann, JAMA Dermatol 2021